KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Resmed (RMD) Shares Outstanding (Diluted Average) (2017 - 2025)

Historic Shares Outstanding (Diluted Average) for Resmed (RMD) over the last 14 years, with Q4 2025 value amounting to $146.6 million.

  • Resmed's Shares Outstanding (Diluted Average) fell 60.13% to $146.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $146.6 million, marking a year-over-year decrease of 60.13%. This contributed to the annual value of $147.3 million for FY2025, which is 14.23% down from last year.
  • According to the latest figures from Q4 2025, Resmed's Shares Outstanding (Diluted Average) is $146.6 million, which was down 60.13% from $146.9 million recorded in Q3 2025.
  • Resmed's 5-year Shares Outstanding (Diluted Average) high stood at $147.6 million for Q3 2024, and its period low was $146.4 million during Q1 2021.
  • In the last 5 years, Resmed's Shares Outstanding (Diluted Average) had a median value of $147.4 million in 2023 and averaged $147.2 million.
  • As far as peak fluctuations go, Resmed's Shares Outstanding (Diluted Average) surged by 54.86% in 2021, and later plummeted by 60.13% in 2025.
  • Over the past 5 years, Resmed's Shares Outstanding (Diluted Average) (Quarter) stood at $147.0 million in 2021, then rose by 0.25% to $147.4 million in 2022, then grew by 0.11% to $147.6 million in 2023, then decreased by 0.04% to $147.5 million in 2024, then fell by 0.6% to $146.6 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $146.6 million for Q4 2025, versus $146.9 million for Q3 2025 and $147.3 million for Q2 2025.